Roles of exercise and pharmacokinetics in cerivastatin-induced skeletal muscle toxicity (Q46686112)

24 December 2017

title

Roles of exercise and pharmacokinetics in cerivastatin-induced skeletal muscle toxicity (English)

1 reference

24 December 2017

1 reference

Jennifer L Seachrist

1

1 reference

24 December 2017

Cho-Ming Loi

2

1 reference

24 December 2017

Mark G Evans

3

1 reference

24 December 2017

Kay A Criswell

4

1 reference

24 December 2017

Charles E Rothwell

5

1 reference

24 December 2017

publication date

1 September 2005

1 reference

24 December 2017

published in

Toxicological Sciences

1 reference

24 December 2017

volume

88

1 reference

24 December 2017

page(s)

551-561

1 reference

24 December 2017

issue

2

1 reference

24 December 2017

Discovery, biochemistry and biology of lovastatin

cites work

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFI305

Ultrastructure of mouse striated muscle fibers following pravastatin administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFI305

Safety considerations for statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFI305

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFI305

Statins initiated after hypertrophy inhibit oxidative stress and prevent heart failure in rats with aortic stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFI305

Lipid-lowering drugs and mitochondrial function: effects of HMG-CoA reductase inhibitors on serum ubiquinone and blood lactate/pyruvate ratio

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFI305

A comprehensive description of muscle symptoms associated with lipid-lowering drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFI305

Differential transcriptional activation of select metabolic genes in response to variations in exercise intensity and duration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFI305

Statins induce apoptosis in rat and human myotube cultures by inhibiting protein geranylgeranylation but not ubiquinone

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFI305

All hydrophobic HMG-CoA reductase inhibitors induce apoptotic death in rat pulmonary vein endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFI305

Potential interactions between exercise and drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFI305

Pleiotropic effects of statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFI305

McArdle's disease diagnosed following statin-induced myositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFI305

Exercise alters the profile of phospholipid molecular species in rat skeletal muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFI305

Effects of simvastatin administration in an experimental model of cancer cachexia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFI305

Myopathy induced by HMG-CoA reductase inhibitors in rabbits: a pathological, electrophysiological, and biochemical study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFI305

Statin precipitated lactic acidosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFI305

Statin-associated myopathy with normal creatine kinase levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFI305

Evaluation of ubiquinone concentration and mitochondrial function relative to cerivastatin-induced skeletal myopathy in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFI305

Lovastatin-induced apoptosis in human melanoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFI305

Professional athletes suffering from familial hypercholesterolaemia rarely tolerate statin treatment because of muscular problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFI305

Simvastatin triggers mitochondria-induced Ca2+ signaling alteration in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFI305

The potential of statins as part of anti-cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFI305

Cerivastatin and reports of fatal rhabdomyolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFI305

Statin-associated myopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFI305

HMG-CoA reductase inhibitors and myotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFI305

Preclinical safety evaluation of cerivastatin, a novel HMG-CoA reductase inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFI305

Statin-induced muscle necrosis in the rat: distribution, development, and fibre selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFI305

Atorvastatin affects leukocyte gene expression in dyslipidemia patients: in vivo regulation of hemostasis, inflammation and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FTOXSCI%2FKFI305

21 January 2018

Identifiers

DOI

10.1093/TOXSCI/KFI305

1 reference

24 December 2017

PubMed ID

16141437

1 reference

24 December 2017